| 1 | phase iii nrtx1001 for | | | | | | | 4 | 1.58% |
| 2 | missionvision leadership board of | | | | | | | 2 | 0.79% |
| 3 | news events careers culture | | | | | | | 2 | 0.79% |
| 4 | the news events careers | | | | | | | 2 | 0.79% |
| 5 | in the news events | | | | | | | 2 | 0.79% |
| 6 | releases in the news | | | | | | | 2 | 0.79% |
| 7 | epilepsy on clinicaltrialsgov news | | | | | | | 2 | 0.79% |
| 8 | for epilepsy on clinicaltrialsgov | | | | | | | 2 | 0.79% |
| 9 | nrtx1001 for epilepsy on | | | | | | | 2 | 0.79% |
| 10 | epilepsy phase iii nrtx1001 | | | | | | | 2 | 0.79% |
| 11 | iii nrtx1001 for epilepsy | | | | | | | 2 | 0.79% |
| 12 | trials phase iii nrtx1001 | | | | | | | 2 | 0.79% |
| 13 | careers culture values benefits | | | | | | | 2 | 0.79% |
| 14 | clinical trials phase iii | | | | | | | 2 | 0.79% |
| 15 | programs clinical trials phase | | | | | | | 2 | 0.79% |
| 16 | pipeline programs clinical trials | | | | | | | 2 | 0.79% |
| 17 | presentations pipeline programs clinical | | | | | | | 2 | 0.79% |
| 18 | approach manufacturing publications scientific | | | | | | | 2 | 0.79% |
| 19 | technology approach manufacturing publications | | | | | | | 2 | 0.79% |
| 20 | investors technology approach manufacturing | | | | | | | 2 | 0.79% |
| 21 | of directors scientific advisors | | | | | | | 2 | 0.79% |
| 22 | board of directors scientific | | | | | | | 2 | 0.79% |
| 23 | leadership board of directors | | | | | | | 2 | 0.79% |
| 24 | events careers culture values | | | | | | | 2 | 0.79% |
| 25 | press releases in the | | | | | | | 2 | 0.79% |
| 26 | visiting scientistsinternship programs job | | | | | | | 2 | 0.79% |
| 27 | scientistsinternship programs job opportunities | | | | | | | 2 | 0.79% |
| 28 | programs job opportunities contact | | | | | | | 2 | 0.79% |
| 29 | science and developing novel | | | | | | | 1 | 0.40% |
| 30 | neuronal glial and geneedited | | | | | | | 1 | 0.40% |
| 31 | includes neuronal glial and | | | | | | | 1 | 0.40% |
| 32 | pipeline includes neuronal glial | | | | | | | 1 | 0.40% |
| 33 | motivated people just like | | | | | | | 1 | 0.40% |
| 34 | people just like yourself | | | | | | | 1 | 0.40% |
| 35 | just like yourself advancing | | | | | | | 1 | 0.40% |
| 36 | and developing novel therapeutics | | | | | | | 1 | 0.40% |
| 37 | teamwork and we welcome | | | | | | | 1 | 0.40% |
| 38 | glial and geneedited cell | | | | | | | 1 | 0.40% |
| 39 | novel therapeutics require passionate | | | | | | | 1 | 0.40% |
| 40 | perseverance innovative thinking diverse | | | | | | | 1 | 0.40% |